genedrive plc
LSE:GDR
GBp 1.08
0 (0%)
EOD - 2026-01-28
Learn the Markets
genedrive plc Price Highlights 🏷️
genedrive plc Price Chart 📈
Buy and Sell genedrive plc 🛒
EToro |
Live Trading |
Buy & Sell
|
Trading 212 |
Live Trading |
Buy & Sell
|
ShareScope |
Paper Trading |
Learn How
|
Investor Returns 👀
Jigglypop Analysis For genedrive plc 🤓
2026-01-16
Genedrive trades at 0.9p, roughly a third up from its 52-week low (0.19p) and well below the 2.4p high, with the price sitting under the 200-day average and hugging the 50-day. That positioning, plus a £9.3m micro-cap and a stated need for near-term financing, frames this firmly as a speculative play rather than a value reset. Operationally, momentum is building: NICE Early Value Assessment is translating into MT-RNR1 usage, Scotland is rolling out neonatal testing, NHS pilots for CYP2C19 are advancing, and a Saudi MoU opens an international pathway. Yet funding clarity remains the swing factor. Expect news-driven volatility; confirmation of financing and NHS procurement traction would de-risk the story, while delays could pressure a still fragile share price further.
About genedrive plc 👋
genedrive plc designs, develops, and manufactures molecular diagnostic testing devices for genotyping, pathogen identification, infectious disease detection, and other clinical applications. Its offerings include the Genedrive system, a rapid nucleic acid thermocycler with fluorescence signal detection for target discrimination used in qualitative in vitro molecular diagnostics; and the Genedrive CYP2C19 ID Kit, a certified assay to identify individuals unlikely to respond to the widely used antiplatelet drug clopidogrel. The company also provides the Genedrive MT-RNR1-ID Kit, a rapid genetic test for emergency neonatal care; assays to detect antibiotic-induced hearing loss in newborns; confirmation of HCV infection prior to therapy; pathogen detection for biological military threats; and a point-of-care COVID-19 testing solution for settings such as healthcare, workplace screening, travel, and antigen test confirmation. It serves the medical, biotechnology, and pharmaceutical sectors in the United Kingdom, Europe, the United States, and globally. Formerly Epistem Holdings Plc, it rebranded to genedrive plc in July 2016. Founded in 2000, it is headquartered in Manchester, United Kingdom.
genedrive plc Price Range 🎯
0.19
2.4
Ownership Breakdown 🤝
genedrive plc Consensus.
Brokers Consensus
genedrive plc Directors.
Trending Tickers View all UK Stocks →
Frequent Asked Questions 💬
LSE:GDR has around 43 people working for the Company.
LSE:GDR belongs to the Healthcare Sector.
The 200 day MA value for genedrive plc is 1.00.
The 50 day MA value for genedrive plc is 0.94.
The ATH price for genedrive plc is 1.15.
The ATL price for genedrive plc is 1.035.